Basecamp Research CEO Glen Gowers was interviewed on CNBC to discuss how the company is building datasets and training models for designing new medicines.
Public source
Publisher name
Public post
Our CEO, Glen Gowers, was recently interviewed on CNBC to discuss how Basecamp Research is building the datasets and training the models needed to design new medicines.…
Company
Basecamp Research
Beyond Known Biology: AI company dedicated to using nature to solve the life sciences' most pressing challenges - BCR
- Industry
- Biotechnology Research
- Location
- London, GB
- Company size
- 51–200 employees
About Basecamp Research
Basecamp Research is an AI company dedicated to solving the most pressing challenges in the life sciences by exploring beyond known biology. The company discovers and designs proteins with artificial intelligence trained on its proprietary knowledge graph of nature, the largest and most diverse of its kind, to design biological solutions for pharma, food and industrial applications. Understanding the full genetic, evolutionary, and environmental context of each protein allows Basecamp Research to design tailored proteins for specific applications without the need for expensive and time-consuming directed evolution campaigns. We're a team of explorers, scientists and policy experts driven by our ambition to protect and learn from nature's diversity, whilst delivering life-changing breakthroughs to those who need them most. – BCR
See moreDiscover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
Orakl Oncology
Orakl Oncology was featured in a piece by Les Echos on how AI is reshaping drug discovery alongside Isomorphic Labs, Chai Discovery, and AQEMIA.
Presence & Recognition
Form Bio
Form Bio CEO Michelle Chen, Ph.D., sat down with synthetic biology pioneer George Church for a masterclass on the future of AI, gene therapy, and programmable medicine in The Algorithm of Life
Presence & Recognition
Tilda Research
Tilda Research Founder and CEO Ram Yalamanchili is quoted in USA TODAY on how AI is helping get new medicines to patients sooner alongside AWS, Genentech, and Sanofi.
Presence & Recognition
Healx
Healx Scientific Associate Director Wayne Chadwick presented at the Angelman Syndrome Foundation's 2026 Research Symposium in Aurora, Colorado, exploring new therapeutic opportunities in Angelman syndrome using AI in drug discovery.
Presence & Recognition
Xaira Therapeutics